| Nov 9 |
Hims & Hers: Undeservedly Undervalued
|
| Nov 8 |
Hims & Hers: A High-Growth Gem On The Verge Of Big Upside
|
| Nov 6 |
Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
|
| Nov 5 |
Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories
|
| Nov 5 |
Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims
|
| Nov 5 |
Hims & Hers Health: Another Blowout Quarter Ignored
|
| Nov 5 |
Hims & Hers to launch a generic for Novo’s older GLP-1
|
| Nov 5 |
Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow
|
| Nov 5 |
Palantir, Trump Media, Hims & Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
|
| Nov 5 |
Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript
|
